scholarly article | Q13442814 |
P356 | DOI | 10.1002/GCC.20371 |
P698 | PubMed publication ID | 16906560 |
P50 | author | Tony E Godfrey | Q57487924 |
Susanne M Gollin | Q39052098 | ||
P2093 | author name string | Xin Huang | |
William E Gooding | |||
Kenneth S McCarty | |||
P2860 | cites work | Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma | Q24317037 |
A consistent pattern ofRIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification | Q56476042 | ||
Recurrent coamplification of cytoskeleton-associated genesEMS1 andSHANK2 withCCND1 in oral squamous cell carcinoma | Q57291863 | ||
A role for common fragile site induction in amplification of human oncogenes | Q63869173 | ||
A guide to fragile sites on human chromosomes | Q67266247 | ||
Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck | Q71067356 | ||
Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression | Q73016393 | ||
Prognostic significance of cyclin D1 amplification and overexpression in oral squamous cell carcinomas | Q73506605 | ||
Cyclin-D1-gene amplification is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinoma | Q74013085 | ||
The Hallmarks of Cancer | Q221226 | ||
Identification of a novel cortactin SH3 domain-binding protein and its localization to growth cones of cultured neurons | Q24522731 | ||
The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites | Q24605485 | ||
Evolution's cauldron: duplication, deletion, and rearrangement in the mouse and human genomes | Q24673122 | ||
Cortactin: coupling membrane dynamics to cortical actin assembly | Q28199365 | ||
A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons | Q28215950 | ||
Detailed map of a region commonly amplified at 11q13-->q14 in human breast carcinoma | Q28266887 | ||
The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression | Q28277156 | ||
Characterization of the EMS1 gene and its product, human Cortactin | Q28289385 | ||
Genome rearrangements in mammalian evolution: lessons from human and mouse genomes | Q28775766 | ||
PipMaker--a web server for aligning two genomic DNA sequences | Q28776457 | ||
Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice | Q33236460 | ||
High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. | Q34038356 | ||
Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene | Q34188440 | ||
Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease | Q34294497 | ||
Coincidence of synteny breakpoints with malignancy-related deletions on human chromosome 3. | Q35143751 | ||
Human and mouse genomic sequences reveal extensive breakpoint reuse in mammalian evolution | Q35146467 | ||
DNA amplification at 11q13 in human cancer: from complexity to perplexity | Q35317211 | ||
Chromosomal instability. | Q35611254 | ||
Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis | Q35982544 | ||
Chromosome rearrangements in evolution: From gene order to genome sequence and back | Q36160426 | ||
Lengths of chromosomal segments conserved since divergence of man and mouse | Q36254112 | ||
Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays | Q36644111 | ||
Chromosomal instability and cytoskeletal defects in oral cancer cells | Q37150932 | ||
Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice | Q38480535 | ||
The involvement of the chromosome 11q13 region in human malignancies: Cyclin D1 and EMS1 are two new candidate oncogenes-a review | Q40442663 | ||
Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer | Q40508410 | ||
Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons | Q41115353 | ||
Immortalization of normal human oral keratinocytes with type 16 human papillomavirus | Q42806823 | ||
Fragile sites in human and Macaca fascicularis chromosomes are breakpoints in chromosome evolution. | Q43894313 | ||
MYEOV, a gene at 11q13, is coamplified with CCND1, but epigenetically inactivated in a subset of esophageal squamous cell carcinomas | Q44119400 | ||
Copy number aberrations in mouse breast tumors reveal loci and genes important in tumorigenic receptor tyrosine kinase signaling | Q46107577 | ||
A region within murine chromosome 7F4, syntenic to the human 11q13 amplicon, is frequently amplified in 4NQO-induced oral cavity tumors | Q48045280 | ||
Telomere dysfunction provokes regional amplification and deletion in cancer genomes. | Q53387305 | ||
P433 | issue | 11 | |
P921 | main subject | transcriptome | Q252857 |
amplicon | Q2844457 | ||
cancer research | Q3421914 | ||
lip and oral cavity carcinoma | Q55790434 | ||
P304 | page(s) | 1058-1069 | |
P577 | publication date | 2006-11-01 | |
P1433 | published in | Genes, Chromosomes and Cancer | Q5532697 |
P1476 | title | Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma | |
P478 | volume | 45 |
Q34122834 | ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines |
Q37103690 | Actin cytoskeletal mediators of motility and invasion amplified and overexpressed in head and neck cancer |
Q40441025 | Alterations in Cell-Extracellular Matrix Interactions during Progression of Cancers |
Q40024956 | Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma |
Q80807833 | Amplification of 11q13 in ovarian carcinoma |
Q38782834 | An update on the implications of cyclin D1 in oral carcinogenesis. |
Q24644782 | Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract |
Q37225309 | Anoctamin and transmembrane channel-like proteins are evolutionarily related. |
Q24645272 | Anoctamin/TMEM16 family members are Ca2+-activated Cl- channels |
Q34186977 | Anoctamins |
Q34576838 | Autosomal recessive nonsyndromic deafness locus DFNB63 at chromosome 11q13.2-q13.3. |
Q53245916 | Calcium-activated chloride current determines action potential morphology during calcium alternans in atrial myocytes. |
Q41283473 | Cell-specific mechanisms of TMEM16A Ca2+-activated chloride channel in cancer |
Q34945762 | Characterization of Cardiac Anoctamin1 Ca²⁺-Activated Chloride Channels and Functional Role in Ischemia-Induced Arrhythmias |
Q34392987 | Characterization of genetic rearrangements in esophageal squamous carcinoma cell lines by a combination of M-FISH and array-CGH: further confirmation of some split genomic regions in primary tumors |
Q39895055 | Characterization of the 7q21-q22 amplicon identifies ARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancer |
Q34581690 | Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature |
Q91875634 | Comparative genomic analysis of collagen gene diversity |
Q40503694 | Copy number gain of 11q13.3 genes associates with pathological stage in hypopharyngeal squamous cell carcinoma |
Q38245688 | Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease |
Q46482594 | DNA methylation regulates TMEM16A/ANO1 expression through multiple CpG islands in head and neck squamous cell carcinoma |
Q54316833 | DOG1: a novel marker of salivary acinar and intercalated duct differentiation. |
Q37305438 | Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy |
Q35661454 | Development of the Olfactory Epithelium and Nasal Glands in TMEM16A-/- and TMEM16A+/+ Mice |
Q33274455 | Discovered on gastrointestinal stromal tumours 1 (DOG1) expression in non-gastrointestinal stromal tumour (GIST) neoplasms |
Q92191060 | Endolysosomal Ca2+ Signaling in Cancer: The Role of TPC2, From Tumorigenesis to Metastasis |
Q34389482 | Enhanced expression of ANO1 in head and neck squamous cell carcinoma causes cell migration and correlates with poor prognosis |
Q30404594 | Etiology of distinct membrane excitability in pre- and posthearing auditory neurons relies on activity of Cl- channel TMEM16A |
Q34144935 | Evolution and functional divergence of the anoctamin family of membrane proteins |
Q33370813 | Expression cloning of TMEM16A as a calcium-activated chloride channel subunit |
Q28510403 | Expression of TMEM16 paralogs during murine embryogenesis |
Q38923517 | Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma |
Q35600924 | Genome-wide expression and copy number analysis identifies driver genes in gingivobuccal cancers |
Q58093851 | Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers |
Q33840816 | Genomic profiling of advanced-stage oral cancers reveals chromosome 11q alterations as markers of poor clinical outcome |
Q36610257 | High-level amplification at 17q23 leads to coordinated overexpression of multiple adjacent genes in breast cancer |
Q28271176 | High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx |
Q40195901 | High-resolution mapping identifies a commonly amplified 11q13.3 region containing multiple genes flanked by segmental duplications |
Q34701235 | Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening |
Q33985351 | Increased complexity of Tmem16a/Anoctamin 1 transcript alternative splicing |
Q28546722 | Inhibition of ANO1/TMEM16A Chloride Channel by Idebenone and Its Cytotoxicity to Cancer Cell Lines |
Q55402499 | Inhibition of ANO1/TMEM16A induces apoptosis in human prostate carcinoma cells by activating TNF-α signaling. |
Q35754730 | Inhibition of Calcium-Activated Chloride Channel ANO1/TMEM16A Suppresses Tumor Growth and Invasion in Human Lung Cancer |
Q28542858 | Inhibition of TMEM16A expression suppresses growth and invasion in human colorectal cancer cells |
Q38741551 | Inhibition of calcium-activated chloride channel ANO1 suppresses proliferation and induces apoptosis of epithelium originated cancer cells |
Q34091528 | Integrative molecular characterization of head and neck cancer cell model genomes |
Q34233287 | International Union of Basic and Clinical Pharmacology. LXXXV: calcium-activated chloride channels. |
Q40134615 | Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma. |
Q39533849 | ORAOV1 is amplified in oral squamous cell carcinoma. |
Q37665253 | Phenomics of cardiac chloride channels |
Q37378258 | Phenomics of cardiac chloride channels: the systematic study of chloride channel function in the heart |
Q37130687 | Physiological roles and diseases of Tmem16/Anoctamin proteins: are they all chloride channels? |
Q90828137 | Prognostic and clinicopathological significance of CTTN/cortactin alterations in head and neck squamous cell carcinoma: Systematic review and meta-analysis |
Q36494146 | Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status |
Q33775591 | Relationships linking amplification level to gene over-expression in gliomas |
Q38184980 | Role of anoctamins in cancer and apoptosis |
Q38633779 | Role of volume-regulated and calcium-activated anion channels in cell volume homeostasis, cancer and drug resistance |
Q38283758 | Roles and regulation of phospholipid scramblases |
Q26851981 | Structure and function of TMEM16 proteins (anoctamins) |
Q48712835 | TMEM16 proteins: the long awaited calcium-activated chloride channels? |
Q28590097 | TMEM16A confers receptor-activated calcium-dependent chloride conductance |
Q39352540 | TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression. |
Q38717360 | TMEM16A/ANO1 suppression improves response to antibody-mediated targeted therapy of EGFR and HER2/ERBB2. |
Q33840138 | TPCs: Endolysosomal channels for Ca2+ mobilization from acidic organelles triggered by NAADP |
Q27011764 | The Ca(2+) -activated Cl(-) channel, ANO1 (TMEM16A), is a double-edged sword in cell proliferation and tumorigenesis |
Q38745675 | The Mechanistic Role of the Calcium-Activated Chloride Channel ANO1 in Tumor Growth and Signaling |
Q47102897 | The Potential for Gut Organoid Derived Interstitial Cells of Cajal in Replacement Therapy |
Q37498502 | The acid test: the discovery of two-pore channels (TPCs) as NAADP-gated endolysosomal Ca(2+) release channels |
Q24292846 | The anoctamin family: TMEM16A and TMEM16B as calcium-activated chloride channels |
Q27935986 | The function of ORAOV1/LTO1, a gene that is overexpressed frequently in cancer: essential roles in the function and biogenesis of the ribosome |
Q28589541 | The transmembrane protein TMEM16A is required for normal development of the murine trachea |
Q52905937 | Tmem16b is specifically expressed in the cilia of olfactory sensory neurons. |
Q58426161 | Tumors of the Upper Aerodigestive Tract |
Q58426138 | Tumors of the upper aerodigestive tract |
Q54215446 | Two-pore channels and disease. |
Search more.